Siemens introduced the AXIOM Sensis XP - a new generation of integrated recording solutions that increases procedural efficiency, allowing for optimal patient care in the cath lab.

Cheetah Medical Inc., developers of the Cheetah NICOM system for non-invasive, real-time cardiac output monitoring, announced that an article entitled "Evaluation of a Noninvasive Continuous Cardiac Output Monitoring System Based on Thoracic Bioreactance" has been accepted for publication in the American Journal of Physiology, a leading journal in the field of cardiac physiology.

As the pioneer of metabolic assessment and behavioral therapy technologies, BodyMedia is developing tools that empower health professionals to better treat patients with chronic health conditions such as obesity, diabetes and cardiovascular disease (CVD).

Agfa HealthCare's Scheduling for Cardiology solution, a Web-enabled scheduling solution for resources management within cardiovascular departments, has been designed to be configurable to multiple, personal-based workflows. Scheduling for Cardiology’s Web-based architecture provides viewing and management of resource availability from any point of access to the hospital network.

ZOLL Medical Corp. has received FDA clearance to market and sell the ZOLL M Series with Real CPR Help technology. The device enables rescuers to instantly see and hear how well they are performing the rate and depth of CPR chest compressions.

The M Series is the Company’s best-selling product to date. The approval extends Real CPR Help to ZOLL’s complete defibrillator product line.

Boston Scientific Corp. announced two-year results from the TAXUS V In-Stent Restenosis (ISR) trial, demonstrating that the TAXUS Express2 paclitaxel-eluting coronary stent system met its primary endpoint in the treatment of in-stent restenosis - the regrowth of diseased tissue into a previously stented artery utilizing bare-metal stents - compared to vascular brachytherapy.


Diagnostic cardiology has experienced revolutionary changes over the past five years as a result of coronary computed tomography angiography (CCTA). The ability to noninvasively obtain three- dimensional anatomic images of technical quality far superior to catheter angiography has forever altered the diagnostic landscape.

Coronary computed tomography angiography (CCTA) has recently made significant technological and clinical advances. Submillimeter slice thickness, increased detectors and reduced acquisition times have multiplied the number of patients that can benefit from noninvasive diagnostic imaging.

The ZOLL R Series is a Code-Ready device that is simple, smart and ready to use. It offers a one step system to simplify and speed up deployment of pacing and defibrillation therapy. It also offers smart tools to help clinicians improve CPR performance, which is important since more than half of in-hospital codes involve non-shockable rhythms and, in such cases, the only treatment is high-quality CPR with minimal interruptions.

Cardiac Science Corp. has launched HeartCentrix, a software solution that enables its diagnostic stress, Holter and electrocardiography devices to communicate seamlessly with physician office-based electronic medical record (EMR) systems.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now